Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion.

MLA

Lenders, Malte, et al. “Characterization of Drug-Neutralizing Antibodies in Patients with Fabry Disease during Infusion.” The Journal of Allergy and Clinical Immunology, vol. 141, no. 6, June 2018, p. 2289. EBSCOhost, https://doi.org/10.1016/j.jaci.2017.12.1001.

APA

Lenders, M., Schmitz, B., Brand, S.-M., Foell, D., & Brand, E. (2018). Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion. The Journal of Allergy and Clinical Immunology, 141(6), 2289. https://doi.org/10.1016/j.jaci.2017.12.1001

Chicago

Lenders, Malte, Boris Schmitz, Stefan-Martin Brand, Dirk Foell, and Eva Brand. 2018. “Characterization of Drug-Neutralizing Antibodies in Patients with Fabry Disease during Infusion.” The Journal of Allergy and Clinical Immunology 141 (6): 2289. doi:10.1016/j.jaci.2017.12.1001.